054180 — Medicox Co Balance Sheet
0.000.00%
IndustrialsHighly SpeculativeMicro Cap
Annual balance sheet for Medicox Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,140 | 18,742 | 24,768 | 17,689 | 6,028 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,320 | 2,517 | 4,280 | 3,901 | 3,243 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,131 | 26,273 | 43,389 | 30,037 | 13,256 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 46,533 | 46,960 | 48,516 | 51,476 | 52,063 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 84,890 | 102,479 | 110,434 | 97,760 | 81,419 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 43,414 | 33,417 | 44,154 | 30,639 | 23,801 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 46,992 | 36,275 | 47,194 | 34,455 | 28,974 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 37,898 | 66,204 | 63,240 | 63,304 | 52,445 |
| Total Liabilities & Shareholders' Equity | 84,890 | 102,479 | 110,434 | 97,760 | 81,419 |
| Total Common Shares Outstanding |